HIV
News
No longer a death sentence, HIV diagnosis still hits hard
People diagnosed now seem to experience more shame and embarrassment than those diagnosed before.
Conference Coverage
Rising viral load on dolutegravir? Investigators try fix before switch
“If you can get through those difficult phases, people can go back on their meds,” he said in an interview. “It’s almost a sociological problem...
Conference Coverage
Results from halted islatravir antiretroviral trial presented
Because of persistent concerns about the impact on CD4+ T cells and total lymphocytes, another phase 3 trial is now underway using a lower 0.25 mg...
Conference Coverage
Injecting long-acting antiretrovirals into clinic care
In the peer staff program, workers are trained in a 4-month medical residency–style program that shows them how to test for HIV, inject long-...
Conference Coverage
UNAIDS targets: Progress reported, but ‘HIV is far from over’
New infections persist at a rate that has not dropped as fast as possible.
Conference Coverage
Low HIV levels linked to ‘almost zero’ risk of sexual transmission
“This [finding] provides a powerful opportunity to help destigmatize HIV, promote the benefits of adhering to antiretroviral therapy, and support...
Conference Coverage
Daily statin cuts cardiovascular risk in HIV
“These are types of people who, if they came to the doctor’s office right now before REPRIEVE, they would largely be told your risk score is not...
Conference Coverage
Long-acting ART effective without viral suppression
“Instead of having the burden of taking a pill every day, patients with HIV can now have these choices of being able to forget about their...
News
Doxy PEP does not lower risk of STIs in cisgender women
Women are known to be at higher risk of infection because the lining of the vagina is thinner than the skin of the penis, allowing for easier...
News
Scientists create ‘vagina on a chip’: What to know
Researchers see the chip as a way to facilitate vaginal health research and open the door to vital new treatments.